Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction

키워드

참고문헌 (52)

1. Kim SW, "Toward a complete cure for chronic hepatitis B : Novel therapeutic targets for hepatitis B virus", Clin Mol Hepatol, 28, pp.17~30 (2022)
2. Tsukuda S, "Hepatitis B virus biology and life cycle", Antiviral Res, 182, pp.104925~ (2020)
3. Song H, "Hepatitis B virus X protein and its host partners", Cell Mol Immunol, 18, pp.1345~1346 (2021)
4. Murphy CM, "Hepatitis B virus X protein promotes degradation of SMC5", 6 to enhance HBV replication, 2016, pp.16, 2846~2854
5. Xie S, "Cytokine profiles and CD8+ T cells in the occurrence of acute and chronic hepatitis B", Front Immunol, 13, pp.1036612~ (2022)
6. Pasquetto V, "Cytokine-sensitive replication of hepatitis B virus in immortalized mouse hepatocyte cultures", J Virol, 76, pp.5646~5653 (2002)
7. Lee SJ, "The IFN-γ-induced transcriptional program of the CIITA gene is inhibited by statins", Eur J Immunol, 38, pp.2325~2336 (2008)
8. Hou J, "Efficacy, safety, and pharmacokinetics of capsid assembly modulator linvencorvir plus standard of care in chronic hepatitis B patients", Clin Mol Hepatol, 30, pp.191~205 (2024)
9. Hui RWH, "RNA interference as a novel treatment strategy for chronic hepatitis B infection", Clin Mol Hepatol, 28, pp.408~424 (2022)
10. Testoni B, "Novel targets for hepatitis B virus therapy", Liver Int, 37(Suppl 1), pp.33~39 (2017)
11. Fanning GC, "Therapeutic strategies for hepatitis B virus infection : towards a cure", Nat Rev Drug Discov, 18, pp.827~844 (2019)
12. Pai RK, "Regulation of class II MHC expression in APCs : roles of types I, III, and IV class II transactivator", J Immunol, 169, pp.1326~1333 (2002)
13. Masternak K, "CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex", Genes Dev, 14, pp.1156~1166 (2000)
14. Accolla RS, "The MHC class II transcriptional activator(CIITA)inhibits HTLV-2 viral replication by blocking the function of the viral transactivator Tax-2", BLOOD, 103, pp.995~1001 (2004)
15. Bruchez A, "MHC class II transactivator CIITA induces cell resistance to Ebola virus and SARS-like coronaviruses", Science, 370, pp.241~247 (2020)
16. Forlani G, "The MHC-II transactivator CIITA inhibits Tat function and HIV-1 replication in human myeloid cells", J Transl Med, 14, pp.94~ (2016)
17. Su M, "Genetic variants in class II transactivator are associated with chronic hepatitis B virus infection in the Han Chinese population", Int J Immunogenet, 47, pp.435~442 (2020)
18. Dezhbord M, "Characterization of the molecular events of covalently closed circular DNA synthesis in de novo Hepatitis B virus infection of human hepatoma cells", Antiviral Res, 163, pp.11~18 (2019)
19. Lee AR, "Distinctive HBV replication capacity and susceptibility to tenofovir induced by a polymerase point mutation in hepatoma cell lines and primary human hepatocytes", Int J Mol Sci, 22, pp.1606~ (2021)
20. Park S, "Suppression of hepatocyte nuclear factor 4 α by long-term infection of hepatitis B virus contributes to tumor cell proliferation", Int J Mol Sci, 21, pp.948~ (2020)
21. Ni Y, "Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes", Gastroenterology, 146, pp.1070~1083 (2014)
22. Kim JC, "Identification and characterization of besifovir-resistant hepatitis B virus isolated from a chronic hepatitis B patient", Biomedicines, 10, pp.282~ (2022)
23. Cai D, "A southern blot assay for detection of hepatitis B virus covalently closed circular DNA from cell cultures", Methods Mol Biol, 1030, pp.151~161 (2013)
24. Zhao Q, "Pregenomic RNA launch hepatitis B virus replication system facilitates the mechanistic study of antiviral agents and drug-resistant variants on covalently closed circular DNA synthesis", J Virol, 96, pp.e0115022~ (2022)
25. Tang L, "DNA polymerase alpha is essential for intracellular amplification of hepatitis B virus covalently closed circular DNA", PLoS Pathog, 15, pp.e1007742~ (2019)
26. Farci P, "B cell gene signature with massive intrahepatic production of antibodies to hepatitis B core antigen in hepatitis B virus-associated acute liver failure", Proc Natl Acad Sci U S A, 107, pp.8766~8771 (2010)
27. Wang H, "TNF-α", IFN-γ profile of HBV-specific CD4 T cells is associated with liver damage and viral clearance in chronic HBV infection, 2020, pp.72, 45~56
28. Kim DH, "Intracellular interleukin-32γ mediates antiviral activity of cytokines against hepatitis B virus", Nat Commun, 9, pp.3284~ (2018)
29. León Machado JA, "The MHC class II transactivator CIITA : Not(quite)the odd-one-out anymore among NLR proteins", Int J Mol Sci, 22, pp.1074~ (2021)
30. Chen EQ, "Study of the expression levels of Hepatocyte nuclear factor 4 alpha and 3 beta in patients with different outcome of HBV infection", Virol J, 9, pp.23~ (2012)
31. Zhao Z, "Mucroporin-M1 inhibits hepatitis B virus replication by activating the mitogen-activated protein kinase(MAPK)pathway and down-regulating HNF4α in vitro and in vivo", J Biol Chem, 287, pp.30181~30190 (2012)
32. Li L, "FoxO4 inhibits HBV core promoter activity through ERK-mediated downregulation of HNF4α", Antiviral Res, 170, pp.104568~ (2019)
33. Li X, "Cytokine-mediated immunopathogenesis of hepatitis B virus infections", Clin Rev Allergy Immunol, 50, pp.41~54 (2016)
34. Zhong S, "Cytokines and chemokines in HBV infection", Front Mol Biosci, 8, pp.805625~ (2021)
35. Zheng Y, "Regulation of hepatitis B virus replication by the ras-mitogen-activated protein kinase signaling pathway", J Virol, 77, pp.7707~7712 (2003)
36. Kumar R, "Role of MAPK", MNK1 signaling in virus replication, 2018, pp.253, 48~61
37. Quasdorff M, "Control of hepatitis B virus at the level of transcription", J Viral Hepat, 17, pp.527~536 (2010)
38. Chin R, "Modulation of MAPK pathways and cell cycle by replicating hepatitis B virus : factors contributing to hepatocarcinogenesis", J Hepatol, 47, pp.325~337 (2007)
39. Kim DH, "Roles of hepatocyte nuclear factors in hepatitis B virus infection", World J Gastroenterol, 22, pp.7017~7029 (2016)
40. Vető B, "The transcriptional activity of hepatocyte nuclear factor 4alpha is inhibited via phosphorylation by ERK1", 2, 2017, pp.12, e0172020~
41. Dai XQ, "Protocatechuic acid inhibits hepatitis B virus replication by activating ERK1", 2 pathway and down-regulating HNF4α and HNF1α in vitro, 2017, pp.180, 68~74
42. Lou B, "Deubiquitinase OTUD5 promotes hepatitis B virus replication by removing K48-linked ubiquitination of HBV core", precore and upregulates HNF4ɑ expressions by inhibiting the ERK1, mitogen-activated protein kinase pathway, pp.Cell Mol Life Sci, 2023[DOI]
43. Nikolaidou-Neokosmidou V, "Inhibition of hepatocyte nuclear factor 4 transcriptional activity by the nuclear factor κB pathway", Biochem J, 398, pp.439~450 (2006)
44. Zassadowski F, "Regulation of the transcriptional activity of nuclear receptors by the MEK", ERK1, Cell Signal, pp.2012, 24[DOI]
45. Casoli C, "The MHC class II transcriptional activator(CIITA)inhibits HTLV-2 viral replication by blocking the function of the viral transactivator Tax-2", Blood, 103, pp.995~1001 (2004)
46. Sartorius K, "The multiple roles of hepatitis B virus X protein(HBx)dysregulated microRNA in hepatitis B virus-associated hepatocellular carcinoma(HBV-HCC)and immune pathways", Viruses, 12, pp.746~ (2020)
47. Hong Y, "Innate immune evasion by hepatitis B virus-mediated downregulation of TRIF", Biochem Biophys Res Commun, 463, pp.719~725 (2015)
48. Sun Y, "Hepatitis B virus-triggered PTEN", β-catenin, Am J Physiol Gastrointest Liver Physiol, pp.2020, 318[DOI]
49. Forgues M, "Interaction of the hepatitis B virus X protein with the Crm1-dependent nuclear export pathway", J Biol Chem, 276, pp.22797~22803 (2001)
50. Morgan JE, "The class II transactivator(CIITA)is regulated by post-translational modification cross-talk between ERK1", 2 phosphorylation, mono-ubiquitination and Lys63 ubiquitination, 2015, pp.35, e00233~
51. Herkel J, "MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocyutes", Hepatology, 37, pp.1079~1085 (2003)
52. Lee AW, "Human cytomegalovirus decreases constitutive transcription of MHC class II genes in mature Langerhans cells by reducing CIITA transcript levels", Mol Immunol, 48, pp.1160~1167 (2011)

관련 논문AI추천